Director
DIN: 00442510
Jashvant Bhogilal Shah is currently associated with 3 companies in various capacities such as Director and Beneficial Owner. They serve as a Director at UNJHA PHARMACY PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 00442510.Jashvant Bhogilal Shah is currently involved in 2 different roles. Their most recent position is with UNJHA PHARMACEUTICALS PRIVATE LIMITED as a Director. The first company Jashvant Bhogilal Shah was appointed to as a director was UNJHA PHARMACY PRIVATE LIMITED. Jashvant Bhogilal Shah is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Jashvant Bhogilal Shah is currently associated with 3 companies in various capacities such as Director and Beneficial Owner. They serve as a Director at UNJHA PHARMACY PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 00442510.Jashvant Bhogilal Shah is currently involved in 2 different roles. Their most recent position is with UNJHA PHARMACEUTICALS PRIVATE LIMITED as a Director. The first company Jashvant Bhogilal Shah was appointed to as a director was UNJHA PHARMACY PRIVATE LIMITED. Jashvant Bhogilal Shah is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
4
Male
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (3)
Current LLPs (0)
Past Companies (0)
7y 1m 3y 7m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| UNJHA PHARMACY PRIVATE LIMITED | Director | 15-Apr-1991 |
| UNJHA PHARMACEUTICALS PRIVATE LIMITED | Director | 20-Nov-2000 |
| AURA NUTRACEUTICALS LIMITED | Director | 16-Oct-2001 |
| UNJHA PHARMACEUTICALS PRIVATE LIMITED | Beneficial Owner | 13-Feb-2021 |